Caribou cuts pipeline and workforce to focus on lead CAR-T programmes
Caribou Biosciences is narrowing its pipeline and reducing its workforce by approximately 32% amid continued challenges in the cell and…
Featured
-
-
Trump order eases Medicare price negotiation for small molecule drugs
US President Donald Trump has issued a broad executive order to lower prescription drug prices in the country, notably including…
-
Can AI replace medical writers? Experts say not immediately
Artificial intelligence (AI) is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but…
-
Streeting promises UK pharma quick action on VPAG frustration
The UK pharma industry can expect resolutions on a range of issues, including VPAG [Voluntary Scheme for Branded Medicines Pricing…
-
ABPI calls on UK Government to resolve “VPAG crisis”
Leaders of the Association of the British Pharmaceutical Industry (ABPI) say the UK Government must address rising clawback rates on…
-
UK life sciences venture capital funding lags behind
In 2024, life sciences was the only tech sector analysed where the UK had not improved its global share of…
-
Saving shelved ultra-rare therapies through unorthodox funding
As a funding drought for biopharma is on the horizon, non-profit biotech Orphan Therapeutics Accelerator is championing an innovative funding…
-
EU Health Data Space strikes a chord in EU harmonisation plans
Amidst a wave of regulatory changes in the European Union (EU) that are underway, the new EU Health Data Space…
-
European agencies catch up with speedier regulatory pathways for CGTs in the US
Although the regulatory landscape for advanced therapy medicinal products (ATMPs) is rapidly evolving, varying regulatory requirements across different regions are…
-
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply
The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial…
